特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
355580

ゲノム編集の世界市場:技術

Genome Editing: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 148 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
ゲノム編集の世界市場:技術
出版日: 2019年02月18日
発行: BCC Research
ページ情報: 英文 148 Pages
納期: 即納可能 即納可能とは
担当者のコメント
それぞれの業界の専門家が執筆する付加価値の高い情報が特徴です。複数冊ご購入にはレポート年間パッケージのご契約をお薦め致します。詳細は右の担当者のおすすめ商品よりご覧下さい。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集市場は、2018年の14億米ドルから、2023年までに44億米ドルまで拡大すると見られています。市場は、2018年~2023年のCAGR (複合年間成長率) で、25.7%の成長が予測されています。

当レポートでは、世界のゲノム編集市場について調査分析し、市場概要、市場区分と予測、セグメント別の市場予測、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 現在のゲノム編集技術

  • 概要
  • ゲノム編集の歴史
  • ゲノム編集の比較
  • CRISPR-Cas9の発見
  • CRISPR-Cas9システムの構成要素
  • CRISPR-Casの仕組み
  • CRISPR-Cas9システムの利点、など

第4章 ゲノム編集の用途

  • イントロダクション
  • 学術研究
  • 創薬・開発
  • 臨床治療
  • 非遺伝子組み換え育種
  • 診断
  • その他

第5章 市場区分と予測

  • 市場概要
  • 市場企業
  • 市場セグメント:地域別
  • 市場セグメント:用途別
  • 市場セグメント:技術別
  • 市場セグメント:製品タイプ別

第6章 受託サービス市場の分析

  • 市場概要
  • 市場企業
  • 市場シェアと予測
  • 製品セグメントとの比較

第7章 研究市場の分析

  • 市場概要
  • 市場シェアと予測
  • 特許分析
  • 出版分析
  • 研究結果分析

第8章 薬剤開発市場の分析

  • 市場概要
  • 市場シェアと予測

第9章 農業バイオテクノロジー市場の分析

  • 市場概要
  • 市場シェアと予測

第10章 臨床市場の分析

  • 市場概要
  • 市場シェアと予測
  • 非臨床市場との比較

第11章 競合情勢と機会

  • 概要
  • 成長戦略
  • 機会

第12章 ゲノム編集市場に影響を与える要因

  • イントロダクション
  • 促進要因
  • 市場成長を制限する要因

第13章 企業プロファイル

BCC Researchについて

図表

List of Tables

  • Summary Table: Global Market for Genome Editing, by Region, Through 2023
    • Table 1: Major Companies That Have Business Related to Genome Editing, July 2018
    • Table 2: Distribution of Companies That Have Genome-Editing-Related Businesses, by Region, July 2018
    • Table 3: Distribution of Companies That Have Genome-Editing-Related Businesses, by U.S. State, July 2018
    • Table 4: Global Market for Genome Editing, by Region, Through 2023
    • Table 5: Global Market for Genome Editing, by Application, Through 2023
    • Table 6: U.S. Market for Genome Editing, by Application, Through 2023
    • Table 7: European Market for Genome Editing, by Application, Through 2023
    • Table 8: Asia-Pacific Market for Genome Editing, by Application, Through 2023
    • Table 9: Rest of World Market for Genome Editing, by Application, Through 2023
    • Table 10: Global Market for Genome Editing, by Technology, Through 2023
    • Table 11: U.S. Market for Genome Editing, by Technology, Through 2023
    • Table 12: European Market for Genome Editing, by Technology, Through 2023
    • Table 13: Asia-Pacific Market for Genome Editing, by Technology, Through 2023
    • Table 14: Rest of World Market for Genome Editing, by Technology, Through 2023
    • Table 15: Global Market for Genome Editing, by Product Type, Through 2023
    • Table 16: U.S. Market for Genome Editing, by Product Type, Through 2023
    • Table 17: European Market for Genome Editing, by Product Type, Through 2023
    • Table 18: Asia-Pacific Market for Genome Editing, by Product Type, Through 2023
    • Table 19: Rest of World Market for Genome Editing, by Product Type, Through 2023
    • Table 20: Major Companies That Provide Genome-Editing-Related Services, July 2018
    • Table 21: Global Market for Genome Editing Services, by Region, Through 2023
    • Table 22: Global Market for Genome Editing, by Product Segment, Through 2023
    • Table 23: U.S. Market for Genome Editing, by Product Segment, Through 2023
    • Table 24: European Market for Genome Editing, by Product Segment, Through 2023
    • Table 25: Asia-Pacific Market for Genome Editing, by Product Segment, Through 2023
    • Table 26: Rest of World Market for Genome Editing, by Product Segment, Through 2023
    • Table 27: Global Academic Research Market for Genome Editing, by Region, Through 2023
    • Table 28: Distribution of Genome Editing Patents and Patent Applications at USPTO, by Country, July 31, 2018
    • Table 29: Distribution of U.S. Genome Editing Patents and Patent Applications at USPTO, by State, July 31, 2018
    • Table 30: Distribution of Genome Editing Patents and Patent Applications at WIPO, by Patent Office, July 31, 2018
    • Table 31: Genome Editing Patents and Patent Applications at USPTO, by Application Year, July 31, 2018
    • Table 32: Genome Editing Patents and Patent Applications at WIPO, by Application Year, July 31, 2018
    • Table 33: Genome Editing Patents and Patent Applications at USPTO, by Technology, July 31, 2018
    • Table 34: NIH Funding for Gene/Genome Editing, by Year
    • Table 35: NIH-Funded Research Grants, by Year
    • Table 36: Global Drug Development Market for Genome Editing, by Region, Through 2023
    • Table 37: Global Plant Breeding Market for Genome Editing, by Region, Through 2023
    • Table 38: Global Market for Genome Editing, by Product Segment, Through 2023
    • Table 39: U.S. Market for Genome Editing, by Product Segment, Through 2023
    • Table 40: European Market for Genome Editing, by Product Segment, Through 2023
    • Table 41: Asia-Pacific Market for Genome Editing, by Product Segment, Through 2023
    • Table 42: Rest of World Market for Genome Editing, by Product Segment, Through 2023

List of Figures

  • Summary Figure: Global Market for Genome Editing, by Region, 2017-2023
    • Figure 1: Distribution Share of Companies That Have Genome-Editing-Related Businesses, by Region, July 2018
    • Figure 2: Global Market for Genome Editing, by Region, 2017-2023
    • Figure 3: Global Genome Editing Market Share, by Region, 2017
    • Figure 4: Global Genome Editing Market Share, by Region, 2023
    • Figure 5: Global Genome Editing Market Share, by Application, 2017
    • Figure 6: Global Genome Editing Market Share, by Application, 2023
    • Figure 7: U.S. Genome Editing Market Share, by Application, 2017
    • Figure 8: U.S. Genome Editing Market Share, by Application, 2023
    • Figure 9: European Genome Editing Market Share, by Application, 2017
    • Figure 10: European Genome Editing Market Share, by Application, 2023
    • Figure 11: Asia-Pacific Genome Editing Market Share, by Application, 2017
    • Figure 12: Asia-Pacific Genome Editing Market Share, by Application, 2023
    • Figure 13: Global Genome Editing Market Share, by Technology, 2017
    • Figure 14: Global Genome Editing Market Share, by Technology, 2023
    • Figure 15: U.S. Genome Editing Market Share, by Technology, 2017
    • Figure 16: U.S. Genome Editing Market Share, by Technology, 2023
    • Figure 17: European Genome Editing Market Share, by Technology, 2017
    • Figure 18: European Genome Editing Market Share, by Technology, 2023
    • Figure 19: Asia-Pacific Genome Editing Market Share, by Technology, 2017
    • Figure 20: Asia-Pacific Genome Editing Market Share, by Technology, 2023
    • Figure 21: Global Genome Editing Market Share, by Product Type, 2017
    • Figure 22: Global Genome Editing Market Share, by Product Type, 2023
    • Figure 23: Global Genome Editing Services Market Share, by Region, 2017
    • Figure 24: Global Genome Editing Services Market Share, by Region, 2023
    • Figure 25: Global Genome Editing Market Share, by Product Segment, 2017
    • Figure 26: Global Genome Editing Market Share, by Product Segment, 2023
    • Figure 27: Global Academic Research Market Share of Genome Editing, by Region, 2017
    • Figure 28: Global Academic Research Market Share of Genome Editing, by Region, 2023
    • Figure 29: Genome Editing Patents and Patent Applications Share, by Technology, July 31, 2018
    • Figure 30: CRISPR Publications, by Year, August 3, 2018
    • Figure 31: ZFNs Publications, by Year
    • Figure 32: TALENs Publications, by Year
    • Figure 33: NIH Funding for Gene/Genome Editing, by Year
    • Figure 34: NIH-Funded Research Grants, by Year
    • Figure 35: Global Drug Development Market Share of Genome Editing, by Region, 2017
    • Figure 36: Global Drug Development Market Share of Genome Editing, by Region, 2023
    • Figure 37: Global Plant Breeding Market Share of Genome Editing, by Region, 2017
    • Figure 38: Global Plant Breeding Market Share of Genome Editing, by Region, 2023
    • Figure 39: Global Clinical Genome Editing Market Share, by Region, 2023
    • Figure 40: Global Genome Editing Market Share, by Product Segment, 2023
目次
Product Code: BIO146B

Report Highlights:

The global market for genome editing should grow from $1.4 billion in 2018 to $4.4 billion by 2023, with a compound annual growth rate (CAGR) of 25.7% for the period of 2018-2023.

U.S. market for genome editing should grow from $535 million in 2018 to $1.7 billion by 2023, with a CAGR of 26.6% for the period of 2018-2023.

Asia-Pacific market for genome editing should grow from $398 million in 2018 to 1.2 billion by 2023, with a CAGR of 25.2% for the period of 2018-2023.

Report Scope:

This study is focused on the market side of genome editing and provides a comprehensive review of genome editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and the Rest of World.

Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth driving factors and the factors that may limit the market's growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

Report Includes:

  • 44 tables
  • A comprehensive overview of the global markets and technologies for genome editing within the industry
  • Analyses of global market trends, with data from 2017, 2018, and projections compound annual growth rates (CAGRs) through 2023
  • Segmentation of the global market by geographical regions, product types, technology types and end-user application areas
  • Emphasis on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products
  • Current status on the intellectual property right of the CRISPR-Cas9 genome editing technology
  • Discussion of the ethical and regulatory issues, as well as patent analysis, publication analysis and research funding in this area
  • Profiles of key players in the industry, including Horizon Discovery, Thermo Fisher Scientific, CRISPR Therapeutics, Caribou Biosciences Inc., Editas Medicine and Vertex

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Key Drivers of Market Growth

Chapter 3: Current Genome Editing Technologies

  • Overview
  • History of Genome Editing
  • Comparison of Genome Editing
  • Discovery of CRISPR-Cas9
  • Components of CRISPR-Cas Systems
    • SgRNA
    • Cas9 Nucleases
  • How CRISPR-Cas Works
  • Advantage of the CRISPR-Cas9 System
  • Popularity of CRISPR Genome Editing
  • Major Technological Issues
    • Efficiency
    • Specificity/Off-Target Effect
    • Delivery Systems
    • Immunogenicity Risk for Clinical Applications
  • A New Genome Editing System: CRISPR-Cpf1
  • Studies on Treating Diseases Using Genome Editing
  • Impact of Genome Editing
  • Future of CRISPR

Chapter 4: Applications of Genome Editing

  • Introduction
  • Academic Research
  • Drug Discovery and Development
  • Clinical Therapy
  • Non-transgenic Breeding
  • Diagnostics
  • Other Applications

Chapter 5: Market Segmentation and Forecast

  • Market Overview
  • Major Players
  • Market Segments by Region
  • Market Segments by Application
  • Market Segments by Technology
  • Market Segments by Product Type

Chapter 6: Contract Services Market Analysis

  • Market Overview
  • Major Players
  • Market Share and Projection
  • Comparison with Products Segment

Chapter 7: Research Market Analysis

  • Market Overview
  • Market Share and Projections
  • Patent Analysis
  • Publication Analysis
  • Research Funding Analysis

Chapter 8: Drug Development Market Analysis

  • Market Overview
  • Market Share and Forecast

Chapter 9: Agricultural Biotechnology Market Analysis

  • Market Overview
  • Market Share and Forecast

Chapter 10: Clinical Market Analysis

  • Market Overview
  • Market Share and Forecast
  • Comparison with Non-clinical Market

Chapter 11: Competition Landscape and Opportunities

  • Overview
  • Growth Strategies
    • Licensing and Agreements
    • Collaborations with Big Biopharmaceutical Companies
    • In-house R&D Program
    • Startup
    • Strategic Alliance and Joint Venture
    • Focus on Specific Application Areas
    • Venture Capital Funding
  • Opportunities

Chapter 12: Factors Influencing the Genome Editing Market

  • Introduction
  • Driving Forces
    • New Genome Editing Technologies and Related Advancements
    • New Applications of Genome Editing
    • Need for Precision Medicine
    • Need for Improving Drug Discovery Process
    • Increasing Demand for Synthetic Genes in Synthetic Biology
    • Investments from Both Public and Private Sectors
    • Increased R&D Expenditures in Related Industrial Sectors
    • High Prevalence of Genetic Birth Disorders
    • Concerns on Genetically Modified Crops
  • Factors Limiting the Market's Growth
    • Stringent Regulatory Frameworks and Time-Consuming Approval Processes
    • Research Funding
    • Patent Disputes
    • Governmental Policies and Regulations
    • Regulatory Uncertainty on Genome Edited Crops
    • Ethical Issues

Chapter 13: Company Profiles

  • ADDGENE
  • AGILENT TECHNOLOGIES INC.
  • ALDEVRON
  • ALLELE BIOTECHNOLOGY
  • AMERICAN TYPE CULTURE COLLECTION (ATCC)
  • APPLIED STEMCELL INC.
  • ARBOR BIOTECHNOLOGIE INC.
  • ASTRAZENECA
  • ATUM (DNA2.0)
  • AUSTRALIAN BIORESOURCES LTD.
  • AXOL BIOSCIENCE LTD.
  • BEAM THERAPEUTICS
  • BIOCYTOGEN
  • BIO-RAD LABORATORIES INC.
  • BIOTOOLS CO. LTD.
  • BLUEBIRD BIO
  • B-MOGEN BIOTECHNOLOGIES INC.
  • CALYXT INC.
  • CANOPY BIOSCIENCES
  • CARIBOU BIOSCIENCES INC.
  • CASZYME
  • CELLECTA INC.
  • CELLECTICS S.A.
  • CIBUS
  • CRISPR THERAPEUTICS
  • DESKTOP GENETICS
  • EDITAS MEDICINE
  • GENECOPOEIA
  • GENEWIZ
  • GENSCRIPT
  • HORIZON DISCOVERY
  • INNOVATIVE GENOMICS INITIATIVE
  • INTELLIA THERAPEUTICS INC.
  • INTEGRATED DNA TECHNOLOGIES
  • IXCELLS BIOTECHNOLOGIES
  • JUNO THERAPEUTICS
  • LONZA
  • MAMMOTH BIOSCIENCES
  • MERCK KGAA (SIGMA-ALDRICH)
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES INC.
  • RECOMBINETICS
  • REGENERON PHARMACEUTALS INC.
  • SANGAMO BIOSCIENCES
  • SOLENTIM INC.
  • SYNTHEGO
  • SYSTEM BIOSCIENCES
  • TAKARA BIO USA INC. (CLONTECH)
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.
  • TRANS GENIC INC.
  • TRANSOMIC TECHNOLOGIES INC.
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • VERTEX PHARMACEUTICALS INC.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.